lipopolysaccharide (lps) (cat Search Results


99
ATCC cath 2 against e coli atcc 25922
<t>E.</t> <t>coli</t> 506 was co-incubated with different CATH-2 concentrations at 37 °C for different time points (1, 5, 10, 30, 60, 120 and 180 min). Each mixture was aliquoted at the various time intervals, serially diluted and spread plated on TSA plates. After 16 h at 37 °C plates were counted for surviving bacteria. Data represent three independent measurements (means ± SEM).
Cath 2 Against E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cath 2 against e coli atcc 25922/product/ATCC
Average 99 stars, based on 1 article reviews
cath 2 against e coli atcc 25922 - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

97
InvivoGen lps eb
<t>E.</t> <t>coli</t> 506 was co-incubated with different CATH-2 concentrations at 37 °C for different time points (1, 5, 10, 30, 60, 120 and 180 min). Each mixture was aliquoted at the various time intervals, serially diluted and spread plated on TSA plates. After 16 h at 37 °C plates were counted for surviving bacteria. Data represent three independent measurements (means ± SEM).
Lps Eb, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lps eb/product/InvivoGen
Average 97 stars, based on 1 article reviews
lps eb - by Bioz Stars, 2026-05
97/100 stars
  Buy from Supplier

96
Cusabio mouse lps elisa kit
<t>E.</t> <t>coli</t> 506 was co-incubated with different CATH-2 concentrations at 37 °C for different time points (1, 5, 10, 30, 60, 120 and 180 min). Each mixture was aliquoted at the various time intervals, serially diluted and spread plated on TSA plates. After 16 h at 37 °C plates were counted for surviving bacteria. Data represent three independent measurements (means ± SEM).
Mouse Lps Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse lps elisa kit/product/Cusabio
Average 96 stars, based on 1 article reviews
mouse lps elisa kit - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

91
GE Healthcare c7pp peptide novopep n a lb media lps solution
(A) Overall structural snapshot of <t>C7pp-bound</t> βarr2 highlighting the loop regions. The C7pp peptide is shown as green sticks and the various loops in βarr2, i.e., the finger, middle, lariat, and C loops in the central crest, are colored in blue, black, orange, and olive, respectively. See also Figure S2.
C7pp Peptide Novopep N A Lb Media Lps Solution, supplied by GE Healthcare, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c7pp peptide novopep n a lb media lps solution/product/GE Healthcare
Average 91 stars, based on 1 article reviews
c7pp peptide novopep n a lb media lps solution - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

90
Beijing Solarbio Science lps chemical
( A ) CCK8 assay was conducted to analyze the toxicity of different doses <t>of</t> <t>BBR</t> (1 μM, 2 μM, 4 μM, 8 μM, or 16 μM) in HMC3 cells. ( B-F ) HMC3 cells were divided into six groups: control, BBR (8 μM), <t>LPS,</t> LPS+BBR (2 μM), LPS+BBR (4 μM), and LPS+BBR (8 μM). For BBR and LPS co-treated group, HMC3 cells were treated with BBR for 3 h, followed by LPS exposure for 24 h. ( B and C ) IF assay was carried out to evaluate the levels of two indicators of inflammation, including iNOS and COX2. ( D-F ) ELISA was implemented to analyze the release of three pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) in the culture supernatant. ns: no statistically significant difference, * P< 0.05, ** P< 0.01, *** P< 0.001.
Lps Chemical, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lps chemical/product/Beijing Solarbio Science
Average 90 stars, based on 1 article reviews
lps chemical - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology anti σ1r
( A ) CCK8 assay was conducted to analyze the toxicity of different doses <t>of</t> <t>BBR</t> (1 μM, 2 μM, 4 μM, 8 μM, or 16 μM) in HMC3 cells. ( B-F ) HMC3 cells were divided into six groups: control, BBR (8 μM), <t>LPS,</t> LPS+BBR (2 μM), LPS+BBR (4 μM), and LPS+BBR (8 μM). For BBR and LPS co-treated group, HMC3 cells were treated with BBR for 3 h, followed by LPS exposure for 24 h. ( B and C ) IF assay was carried out to evaluate the levels of two indicators of inflammation, including iNOS and COX2. ( D-F ) ELISA was implemented to analyze the release of three pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) in the culture supernatant. ns: no statistically significant difference, * P< 0.05, ** P< 0.01, *** P< 0.001.
Anti σ1r, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti σ1r/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
anti σ1r - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

93
Cusabio lps elisa
Elevated levels of BPI present in plasma and BAL of people with CF. (A , B) <t>LPS</t> levels in CF plasma and BAL correlated with CF-ABLE score. Quantification of an association between variables was achieved by Spearman correlation. (C , D) Comparative analysis of BPI present in plasma or BAL of Phe508del homozygous PWCF (CF), healthy controls (HC) or NCFB patients was performed by <t>ELISA.</t> (C) BPI levels were significantly increased in plasma of CF compared to HC (n=22 and n=14 subjects per group, respectively, p=0.007, Mann Whitney U-test). (D) BAL levels of BPI were significantly increased in CF (n=5) compared to HC (n=4) or NCFB patients (n=5) (p<0.0001, One-way ANOVA, followed by Bonferroni post-hoc test for selected groups). (E) BAL samples from HC, CF, NCFB or COPD were subjected to SDS-PAGE and Western blot analysis for BPI. An immuno-band of increased intensity for BPI was detected in CF BAL samples (top panels). Lower panel, a control immunoblot to ensure BPI specificity. The blot was halved, with one half probed with secondary antibody only with no BPI immune-bands visible (↑ indicates where blot was cut). Human BPI (hBPI) was used as a positive control. All measurements are means ± SEM from biological replicates.
Lps Elisa, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lps elisa/product/Cusabio
Average 93 stars, based on 1 article reviews
lps elisa - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

96
InvivoGen lps stimulation
Elevated levels of BPI present in plasma and BAL of people with CF. (A , B) <t>LPS</t> levels in CF plasma and BAL correlated with CF-ABLE score. Quantification of an association between variables was achieved by Spearman correlation. (C , D) Comparative analysis of BPI present in plasma or BAL of Phe508del homozygous PWCF (CF), healthy controls (HC) or NCFB patients was performed by <t>ELISA.</t> (C) BPI levels were significantly increased in plasma of CF compared to HC (n=22 and n=14 subjects per group, respectively, p=0.007, Mann Whitney U-test). (D) BAL levels of BPI were significantly increased in CF (n=5) compared to HC (n=4) or NCFB patients (n=5) (p<0.0001, One-way ANOVA, followed by Bonferroni post-hoc test for selected groups). (E) BAL samples from HC, CF, NCFB or COPD were subjected to SDS-PAGE and Western blot analysis for BPI. An immuno-band of increased intensity for BPI was detected in CF BAL samples (top panels). Lower panel, a control immunoblot to ensure BPI specificity. The blot was halved, with one half probed with secondary antibody only with no BPI immune-bands visible (↑ indicates where blot was cut). Human BPI (hBPI) was used as a positive control. All measurements are means ± SEM from biological replicates.
Lps Stimulation, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lps stimulation/product/InvivoGen
Average 96 stars, based on 1 article reviews
lps stimulation - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

97
InvivoGen lps
Elevated levels of BPI present in plasma and BAL of people with CF. (A , B) <t>LPS</t> levels in CF plasma and BAL correlated with CF-ABLE score. Quantification of an association between variables was achieved by Spearman correlation. (C , D) Comparative analysis of BPI present in plasma or BAL of Phe508del homozygous PWCF (CF), healthy controls (HC) or NCFB patients was performed by <t>ELISA.</t> (C) BPI levels were significantly increased in plasma of CF compared to HC (n=22 and n=14 subjects per group, respectively, p=0.007, Mann Whitney U-test). (D) BAL levels of BPI were significantly increased in CF (n=5) compared to HC (n=4) or NCFB patients (n=5) (p<0.0001, One-way ANOVA, followed by Bonferroni post-hoc test for selected groups). (E) BAL samples from HC, CF, NCFB or COPD were subjected to SDS-PAGE and Western blot analysis for BPI. An immuno-band of increased intensity for BPI was detected in CF BAL samples (top panels). Lower panel, a control immunoblot to ensure BPI specificity. The blot was halved, with one half probed with secondary antibody only with no BPI immune-bands visible (↑ indicates where blot was cut). Human BPI (hBPI) was used as a positive control. All measurements are means ± SEM from biological replicates.
Lps, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lps/product/InvivoGen
Average 97 stars, based on 1 article reviews
lps - by Bioz Stars, 2026-05
97/100 stars
  Buy from Supplier

90
PeproTech il-4 peprotech
Elevated levels of BPI present in plasma and BAL of people with CF. (A , B) <t>LPS</t> levels in CF plasma and BAL correlated with CF-ABLE score. Quantification of an association between variables was achieved by Spearman correlation. (C , D) Comparative analysis of BPI present in plasma or BAL of Phe508del homozygous PWCF (CF), healthy controls (HC) or NCFB patients was performed by <t>ELISA.</t> (C) BPI levels were significantly increased in plasma of CF compared to HC (n=22 and n=14 subjects per group, respectively, p=0.007, Mann Whitney U-test). (D) BAL levels of BPI were significantly increased in CF (n=5) compared to HC (n=4) or NCFB patients (n=5) (p<0.0001, One-way ANOVA, followed by Bonferroni post-hoc test for selected groups). (E) BAL samples from HC, CF, NCFB or COPD were subjected to SDS-PAGE and Western blot analysis for BPI. An immuno-band of increased intensity for BPI was detected in CF BAL samples (top panels). Lower panel, a control immunoblot to ensure BPI specificity. The blot was halved, with one half probed with secondary antibody only with no BPI immune-bands visible (↑ indicates where blot was cut). Human BPI (hBPI) was used as a positive control. All measurements are means ± SEM from biological replicates.
Il 4 Peprotech, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il-4 peprotech/product/PeproTech
Average 90 stars, based on 1 article reviews
il-4 peprotech - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Merck KGaA lps e. coli o26:b6
Elevated levels of BPI present in plasma and BAL of people with CF. (A , B) <t>LPS</t> levels in CF plasma and BAL correlated with CF-ABLE score. Quantification of an association between variables was achieved by Spearman correlation. (C , D) Comparative analysis of BPI present in plasma or BAL of Phe508del homozygous PWCF (CF), healthy controls (HC) or NCFB patients was performed by <t>ELISA.</t> (C) BPI levels were significantly increased in plasma of CF compared to HC (n=22 and n=14 subjects per group, respectively, p=0.007, Mann Whitney U-test). (D) BAL levels of BPI were significantly increased in CF (n=5) compared to HC (n=4) or NCFB patients (n=5) (p<0.0001, One-way ANOVA, followed by Bonferroni post-hoc test for selected groups). (E) BAL samples from HC, CF, NCFB or COPD were subjected to SDS-PAGE and Western blot analysis for BPI. An immuno-band of increased intensity for BPI was detected in CF BAL samples (top panels). Lower panel, a control immunoblot to ensure BPI specificity. The blot was halved, with one half probed with secondary antibody only with no BPI immune-bands visible (↑ indicates where blot was cut). Human BPI (hBPI) was used as a positive control. All measurements are means ± SEM from biological replicates.
Lps E. Coli O26:B6, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lps e. coli o26:b6/product/Merck KGaA
Average 90 stars, based on 1 article reviews
lps e. coli o26:b6 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

97
MedChemExpress medchemexpress llc
Elevated levels of BPI present in plasma and BAL of people with CF. (A , B) <t>LPS</t> levels in CF plasma and BAL correlated with CF-ABLE score. Quantification of an association between variables was achieved by Spearman correlation. (C , D) Comparative analysis of BPI present in plasma or BAL of Phe508del homozygous PWCF (CF), healthy controls (HC) or NCFB patients was performed by <t>ELISA.</t> (C) BPI levels were significantly increased in plasma of CF compared to HC (n=22 and n=14 subjects per group, respectively, p=0.007, Mann Whitney U-test). (D) BAL levels of BPI were significantly increased in CF (n=5) compared to HC (n=4) or NCFB patients (n=5) (p<0.0001, One-way ANOVA, followed by Bonferroni post-hoc test for selected groups). (E) BAL samples from HC, CF, NCFB or COPD were subjected to SDS-PAGE and Western blot analysis for BPI. An immuno-band of increased intensity for BPI was detected in CF BAL samples (top panels). Lower panel, a control immunoblot to ensure BPI specificity. The blot was halved, with one half probed with secondary antibody only with no BPI immune-bands visible (↑ indicates where blot was cut). Human BPI (hBPI) was used as a positive control. All measurements are means ± SEM from biological replicates.
Medchemexpress Llc, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/medchemexpress llc/product/MedChemExpress
Average 97 stars, based on 1 article reviews
medchemexpress llc - by Bioz Stars, 2026-05
97/100 stars
  Buy from Supplier

Image Search Results


E. coli 506 was co-incubated with different CATH-2 concentrations at 37 °C for different time points (1, 5, 10, 30, 60, 120 and 180 min). Each mixture was aliquoted at the various time intervals, serially diluted and spread plated on TSA plates. After 16 h at 37 °C plates were counted for surviving bacteria. Data represent three independent measurements (means ± SEM).

Journal: Scientific Reports

Article Title: Imaging the antimicrobial mechanism(s) of cathelicidin-2

doi: 10.1038/srep32948

Figure Lengend Snippet: E. coli 506 was co-incubated with different CATH-2 concentrations at 37 °C for different time points (1, 5, 10, 30, 60, 120 and 180 min). Each mixture was aliquoted at the various time intervals, serially diluted and spread plated on TSA plates. After 16 h at 37 °C plates were counted for surviving bacteria. Data represent three independent measurements (means ± SEM).

Article Snippet: MIC values of CATH-2 against E. coli ATCC 25922 (smooth LPS) were 2–8 fold higher than rough LPS containing E. coli K12 strains, suggesting that CATH-2 binds to the O-antigen part of LPS ( ).

Techniques: Incubation, Bacteria

Various time lapses within a 6 min period are shown ( a ). Additionally, the fluorescent intensity of FITC-CATH-2 (0.9 μM) and PI (5.1 μM) was measured in both parts of a dividing bacterium ( E. coli 506), based on transverse linescans (yellow line) ( b ). Heat intensity plots show the specific binding sites of FITC-CATH-2 and PI ( c ). Bars, 1 μm.

Journal: Scientific Reports

Article Title: Imaging the antimicrobial mechanism(s) of cathelicidin-2

doi: 10.1038/srep32948

Figure Lengend Snippet: Various time lapses within a 6 min period are shown ( a ). Additionally, the fluorescent intensity of FITC-CATH-2 (0.9 μM) and PI (5.1 μM) was measured in both parts of a dividing bacterium ( E. coli 506), based on transverse linescans (yellow line) ( b ). Heat intensity plots show the specific binding sites of FITC-CATH-2 and PI ( c ). Bars, 1 μm.

Article Snippet: MIC values of CATH-2 against E. coli ATCC 25922 (smooth LPS) were 2–8 fold higher than rough LPS containing E. coli K12 strains, suggesting that CATH-2 binds to the O-antigen part of LPS ( ).

Techniques: Binding Assay

MIC values of  CATH-2 against E. coli  strains with rough and smooth LPS.

Journal: Scientific Reports

Article Title: Imaging the antimicrobial mechanism(s) of cathelicidin-2

doi: 10.1038/srep32948

Figure Lengend Snippet: MIC values of CATH-2 against E. coli strains with rough and smooth LPS.

Article Snippet: MIC values of CATH-2 against E. coli ATCC 25922 (smooth LPS) were 2–8 fold higher than rough LPS containing E. coli K12 strains, suggesting that CATH-2 binds to the O-antigen part of LPS ( ).

Techniques:

(A) Overall structural snapshot of C7pp-bound βarr2 highlighting the loop regions. The C7pp peptide is shown as green sticks and the various loops in βarr2, i.e., the finger, middle, lariat, and C loops in the central crest, are colored in blue, black, orange, and olive, respectively. See also Figure S2.

Journal: Structure (London, England : 1993)

Article Title: Crystal Structure of β-Arrestin 2 in Complex with CXCR7 Phosphopeptide

doi: 10.1016/j.str.2020.06.002

Figure Lengend Snippet: (A) Overall structural snapshot of C7pp-bound βarr2 highlighting the loop regions. The C7pp peptide is shown as green sticks and the various loops in βarr2, i.e., the finger, middle, lariat, and C loops in the central crest, are colored in blue, black, orange, and olive, respectively. See also Figure S2.

Article Snippet: table ft1 table-wrap mode="anchored" t5 REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies HRP-coupled Protein-L antibody GenScript Cat# M00098 Fab 30 This study N/A HRP-coupled M2 anti-FLAG antibody Sigma-Aldrich Cat# A8592; RRID: AB_439702 Bacterial and Virus Strains E. coli cells BL21(DE3)pLysS Novogen Cat# 71403 Chemicals, Peptides, and Recombinant Proteins Protein-L beads GE Healthcare Cat# 17547802 C7pp peptide NovoPep N/A LB media LPS solution Cat# LB-005 Chloramphenicol Bio Basic Inc. Cat# 56757 Kanamycin LPS solution Cat# KAN025 M9 minimal salt media Sigma-Aldrich Cat# MKCF5138 IPTG LPS solution Cat# IPTG025 PMSF Bio Basic Inc. Cat# PB0425 ParatoneⓇ N oil Sigma-Aldrich Cat# HR2-643 n -dodecyl-β-D-maltopyranoside Anatrace Cat# D310S Deposited Data Rat βarr2-C7pp complex structure This study 6K3F Bos Taurus βarr2 Zhan et al., 2011 3P2D Bos Taurus βarr2 Chen et al., 2017 5TV1 Bovine βarr1 Milano et al., 2002 1JSY Bos Taurus βarr1 Kang et al., 2009 3GC3 Rat βarr1 Shukla et al., 2013 4JQI Bos Taurus βarr1 Han et al., 2001 1G4M Ambystoma tigrinum visual arr1 Sutton et al., 2005 1SUJ Bos Taurus visual arr1 Hirsch et al., 1999 1CF1 Bos Taurus visual arr1 Granzin et al., 2012 3UGX Bos Taurus visual arr1 Granzin et al., 2012 3UGU Bos Taurus visual arr1 Granzin et al., 2015 4ZRG Bos Taurus visual arr1 Granzin et al., 1998 1AYR Mouse visual arr1 Kang et al., 2015 4ZWJ Mouse visual arr1 Zhou et al., 2017 5W0P Squid visual arr1 Bandyopadhyay et al., 2018 6BK9 Experimental Models: Cell Lines HEK-293 cells ATCC Cat# CRL-3216 HTLA cells Barnea et al., 2008 N/A Recombinant DNA pET28a-βarr2 1-410 This study N/A pET28a-βarr2 1-356 This study N/A Software and Algorithms GraphPad Prism 6.0 GraphPad graphpad.com PyMol 1.8 Schrodinger LLC pymol.org Phaser McCoy et al., 2007 phenix-online.org COOT Emsley and Cowtan, 2004 mrc-lmb.cam.ac.uk REFMAC5 Murshudov et al., 1997 ccp4.ac.uk/html/refmac5.html XDS Kabsch, 2010 xds.mpimf-heidelberg.mpg.de ProteinLynx Global Server (PLGS) 2.4 Waters waters.com DynamX 2.0 Waters waters.com Other Ni-sepharose affinity column GE Healthcare Cat# 17256801 Desalting column GE Healthcare Cat# 17085101 HiTrap Q sepharose column GE Healthcare Cat# 17115401 HiLoad 16/60 Superdex 200 GE Healthcare Cat# 28989335 HiTrap heparin column GE Healthcare Cat# 17040701 96-well MaxiSorp polystyrene plates Sigma-Aldrich Cat# P6366 Open in a separate window Key Resources Table Resource Availability Lead Contact Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Hyung Ho Lee ( rk.ca.uns@eelohgnuyh ).

Techniques:

Statistics for Data Collection and Refinement

Journal: Structure (London, England : 1993)

Article Title: Crystal Structure of β-Arrestin 2 in Complex with CXCR7 Phosphopeptide

doi: 10.1016/j.str.2020.06.002

Figure Lengend Snippet: Statistics for Data Collection and Refinement

Article Snippet: table ft1 table-wrap mode="anchored" t5 REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies HRP-coupled Protein-L antibody GenScript Cat# M00098 Fab 30 This study N/A HRP-coupled M2 anti-FLAG antibody Sigma-Aldrich Cat# A8592; RRID: AB_439702 Bacterial and Virus Strains E. coli cells BL21(DE3)pLysS Novogen Cat# 71403 Chemicals, Peptides, and Recombinant Proteins Protein-L beads GE Healthcare Cat# 17547802 C7pp peptide NovoPep N/A LB media LPS solution Cat# LB-005 Chloramphenicol Bio Basic Inc. Cat# 56757 Kanamycin LPS solution Cat# KAN025 M9 minimal salt media Sigma-Aldrich Cat# MKCF5138 IPTG LPS solution Cat# IPTG025 PMSF Bio Basic Inc. Cat# PB0425 ParatoneⓇ N oil Sigma-Aldrich Cat# HR2-643 n -dodecyl-β-D-maltopyranoside Anatrace Cat# D310S Deposited Data Rat βarr2-C7pp complex structure This study 6K3F Bos Taurus βarr2 Zhan et al., 2011 3P2D Bos Taurus βarr2 Chen et al., 2017 5TV1 Bovine βarr1 Milano et al., 2002 1JSY Bos Taurus βarr1 Kang et al., 2009 3GC3 Rat βarr1 Shukla et al., 2013 4JQI Bos Taurus βarr1 Han et al., 2001 1G4M Ambystoma tigrinum visual arr1 Sutton et al., 2005 1SUJ Bos Taurus visual arr1 Hirsch et al., 1999 1CF1 Bos Taurus visual arr1 Granzin et al., 2012 3UGX Bos Taurus visual arr1 Granzin et al., 2012 3UGU Bos Taurus visual arr1 Granzin et al., 2015 4ZRG Bos Taurus visual arr1 Granzin et al., 1998 1AYR Mouse visual arr1 Kang et al., 2015 4ZWJ Mouse visual arr1 Zhou et al., 2017 5W0P Squid visual arr1 Bandyopadhyay et al., 2018 6BK9 Experimental Models: Cell Lines HEK-293 cells ATCC Cat# CRL-3216 HTLA cells Barnea et al., 2008 N/A Recombinant DNA pET28a-βarr2 1-410 This study N/A pET28a-βarr2 1-356 This study N/A Software and Algorithms GraphPad Prism 6.0 GraphPad graphpad.com PyMol 1.8 Schrodinger LLC pymol.org Phaser McCoy et al., 2007 phenix-online.org COOT Emsley and Cowtan, 2004 mrc-lmb.cam.ac.uk REFMAC5 Murshudov et al., 1997 ccp4.ac.uk/html/refmac5.html XDS Kabsch, 2010 xds.mpimf-heidelberg.mpg.de ProteinLynx Global Server (PLGS) 2.4 Waters waters.com DynamX 2.0 Waters waters.com Other Ni-sepharose affinity column GE Healthcare Cat# 17256801 Desalting column GE Healthcare Cat# 17085101 HiTrap Q sepharose column GE Healthcare Cat# 17115401 HiLoad 16/60 Superdex 200 GE Healthcare Cat# 28989335 HiTrap heparin column GE Healthcare Cat# 17040701 96-well MaxiSorp polystyrene plates Sigma-Aldrich Cat# P6366 Open in a separate window Key Resources Table Resource Availability Lead Contact Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Hyung Ho Lee ( rk.ca.uns@eelohgnuyh ).

Techniques:

(A) Structural comparisons of the finger, middle, lariat, and C loops in C7pp-bound βarr2 (PDB: 6K3F, blue), R175E visual arr1 (PDB: 4ZRG, orange), IP6-bound βarr2 (PDB: 5TV1, light blue), and V2Rpp-bound βarr1 (PDB: 4JQI, light cyan).

Journal: Structure (London, England : 1993)

Article Title: Crystal Structure of β-Arrestin 2 in Complex with CXCR7 Phosphopeptide

doi: 10.1016/j.str.2020.06.002

Figure Lengend Snippet: (A) Structural comparisons of the finger, middle, lariat, and C loops in C7pp-bound βarr2 (PDB: 6K3F, blue), R175E visual arr1 (PDB: 4ZRG, orange), IP6-bound βarr2 (PDB: 5TV1, light blue), and V2Rpp-bound βarr1 (PDB: 4JQI, light cyan).

Article Snippet: table ft1 table-wrap mode="anchored" t5 REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies HRP-coupled Protein-L antibody GenScript Cat# M00098 Fab 30 This study N/A HRP-coupled M2 anti-FLAG antibody Sigma-Aldrich Cat# A8592; RRID: AB_439702 Bacterial and Virus Strains E. coli cells BL21(DE3)pLysS Novogen Cat# 71403 Chemicals, Peptides, and Recombinant Proteins Protein-L beads GE Healthcare Cat# 17547802 C7pp peptide NovoPep N/A LB media LPS solution Cat# LB-005 Chloramphenicol Bio Basic Inc. Cat# 56757 Kanamycin LPS solution Cat# KAN025 M9 minimal salt media Sigma-Aldrich Cat# MKCF5138 IPTG LPS solution Cat# IPTG025 PMSF Bio Basic Inc. Cat# PB0425 ParatoneⓇ N oil Sigma-Aldrich Cat# HR2-643 n -dodecyl-β-D-maltopyranoside Anatrace Cat# D310S Deposited Data Rat βarr2-C7pp complex structure This study 6K3F Bos Taurus βarr2 Zhan et al., 2011 3P2D Bos Taurus βarr2 Chen et al., 2017 5TV1 Bovine βarr1 Milano et al., 2002 1JSY Bos Taurus βarr1 Kang et al., 2009 3GC3 Rat βarr1 Shukla et al., 2013 4JQI Bos Taurus βarr1 Han et al., 2001 1G4M Ambystoma tigrinum visual arr1 Sutton et al., 2005 1SUJ Bos Taurus visual arr1 Hirsch et al., 1999 1CF1 Bos Taurus visual arr1 Granzin et al., 2012 3UGX Bos Taurus visual arr1 Granzin et al., 2012 3UGU Bos Taurus visual arr1 Granzin et al., 2015 4ZRG Bos Taurus visual arr1 Granzin et al., 1998 1AYR Mouse visual arr1 Kang et al., 2015 4ZWJ Mouse visual arr1 Zhou et al., 2017 5W0P Squid visual arr1 Bandyopadhyay et al., 2018 6BK9 Experimental Models: Cell Lines HEK-293 cells ATCC Cat# CRL-3216 HTLA cells Barnea et al., 2008 N/A Recombinant DNA pET28a-βarr2 1-410 This study N/A pET28a-βarr2 1-356 This study N/A Software and Algorithms GraphPad Prism 6.0 GraphPad graphpad.com PyMol 1.8 Schrodinger LLC pymol.org Phaser McCoy et al., 2007 phenix-online.org COOT Emsley and Cowtan, 2004 mrc-lmb.cam.ac.uk REFMAC5 Murshudov et al., 1997 ccp4.ac.uk/html/refmac5.html XDS Kabsch, 2010 xds.mpimf-heidelberg.mpg.de ProteinLynx Global Server (PLGS) 2.4 Waters waters.com DynamX 2.0 Waters waters.com Other Ni-sepharose affinity column GE Healthcare Cat# 17256801 Desalting column GE Healthcare Cat# 17085101 HiTrap Q sepharose column GE Healthcare Cat# 17115401 HiLoad 16/60 Superdex 200 GE Healthcare Cat# 28989335 HiTrap heparin column GE Healthcare Cat# 17040701 96-well MaxiSorp polystyrene plates Sigma-Aldrich Cat# P6366 Open in a separate window Key Resources Table Resource Availability Lead Contact Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Hyung Ho Lee ( rk.ca.uns@eelohgnuyh ).

Techniques:

(A) An overall distinct binding mode of C7pp with βarr2 (PDB: 6K3F, green) compared with the V2Rpp-βarr1 complex (PDB: 4JQI, light cyan). The N domains from the crystal structures of the C7pp-βarr2 complex and V2Rpp-βarr1 are superimposed and the respective phosphopeptides are highlighted for comparison.

Journal: Structure (London, England : 1993)

Article Title: Crystal Structure of β-Arrestin 2 in Complex with CXCR7 Phosphopeptide

doi: 10.1016/j.str.2020.06.002

Figure Lengend Snippet: (A) An overall distinct binding mode of C7pp with βarr2 (PDB: 6K3F, green) compared with the V2Rpp-βarr1 complex (PDB: 4JQI, light cyan). The N domains from the crystal structures of the C7pp-βarr2 complex and V2Rpp-βarr1 are superimposed and the respective phosphopeptides are highlighted for comparison.

Article Snippet: table ft1 table-wrap mode="anchored" t5 REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies HRP-coupled Protein-L antibody GenScript Cat# M00098 Fab 30 This study N/A HRP-coupled M2 anti-FLAG antibody Sigma-Aldrich Cat# A8592; RRID: AB_439702 Bacterial and Virus Strains E. coli cells BL21(DE3)pLysS Novogen Cat# 71403 Chemicals, Peptides, and Recombinant Proteins Protein-L beads GE Healthcare Cat# 17547802 C7pp peptide NovoPep N/A LB media LPS solution Cat# LB-005 Chloramphenicol Bio Basic Inc. Cat# 56757 Kanamycin LPS solution Cat# KAN025 M9 minimal salt media Sigma-Aldrich Cat# MKCF5138 IPTG LPS solution Cat# IPTG025 PMSF Bio Basic Inc. Cat# PB0425 ParatoneⓇ N oil Sigma-Aldrich Cat# HR2-643 n -dodecyl-β-D-maltopyranoside Anatrace Cat# D310S Deposited Data Rat βarr2-C7pp complex structure This study 6K3F Bos Taurus βarr2 Zhan et al., 2011 3P2D Bos Taurus βarr2 Chen et al., 2017 5TV1 Bovine βarr1 Milano et al., 2002 1JSY Bos Taurus βarr1 Kang et al., 2009 3GC3 Rat βarr1 Shukla et al., 2013 4JQI Bos Taurus βarr1 Han et al., 2001 1G4M Ambystoma tigrinum visual arr1 Sutton et al., 2005 1SUJ Bos Taurus visual arr1 Hirsch et al., 1999 1CF1 Bos Taurus visual arr1 Granzin et al., 2012 3UGX Bos Taurus visual arr1 Granzin et al., 2012 3UGU Bos Taurus visual arr1 Granzin et al., 2015 4ZRG Bos Taurus visual arr1 Granzin et al., 1998 1AYR Mouse visual arr1 Kang et al., 2015 4ZWJ Mouse visual arr1 Zhou et al., 2017 5W0P Squid visual arr1 Bandyopadhyay et al., 2018 6BK9 Experimental Models: Cell Lines HEK-293 cells ATCC Cat# CRL-3216 HTLA cells Barnea et al., 2008 N/A Recombinant DNA pET28a-βarr2 1-410 This study N/A pET28a-βarr2 1-356 This study N/A Software and Algorithms GraphPad Prism 6.0 GraphPad graphpad.com PyMol 1.8 Schrodinger LLC pymol.org Phaser McCoy et al., 2007 phenix-online.org COOT Emsley and Cowtan, 2004 mrc-lmb.cam.ac.uk REFMAC5 Murshudov et al., 1997 ccp4.ac.uk/html/refmac5.html XDS Kabsch, 2010 xds.mpimf-heidelberg.mpg.de ProteinLynx Global Server (PLGS) 2.4 Waters waters.com DynamX 2.0 Waters waters.com Other Ni-sepharose affinity column GE Healthcare Cat# 17256801 Desalting column GE Healthcare Cat# 17085101 HiTrap Q sepharose column GE Healthcare Cat# 17115401 HiLoad 16/60 Superdex 200 GE Healthcare Cat# 28989335 HiTrap heparin column GE Healthcare Cat# 17040701 96-well MaxiSorp polystyrene plates Sigma-Aldrich Cat# P6366 Open in a separate window Key Resources Table Resource Availability Lead Contact Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Hyung Ho Lee ( rk.ca.uns@eelohgnuyh ).

Techniques: Binding Assay

Surface representation of the overall electrostatic potential of the C7pp-bound βarr2 structure. C7pp is shown as green sticks. In the positive electrostatic surface of the N domain, the four hotspots for C7pp binding are shown in the dotted rectangle or circles (F, P, A, and B). The panels on the right represent the detailed interactions at the βarr2-C7pp interface and specific interactions of the phosphates with various residues in βarr2. See also Figures S1B and S6.

Journal: Structure (London, England : 1993)

Article Title: Crystal Structure of β-Arrestin 2 in Complex with CXCR7 Phosphopeptide

doi: 10.1016/j.str.2020.06.002

Figure Lengend Snippet: Surface representation of the overall electrostatic potential of the C7pp-bound βarr2 structure. C7pp is shown as green sticks. In the positive electrostatic surface of the N domain, the four hotspots for C7pp binding are shown in the dotted rectangle or circles (F, P, A, and B). The panels on the right represent the detailed interactions at the βarr2-C7pp interface and specific interactions of the phosphates with various residues in βarr2. See also Figures S1B and S6.

Article Snippet: table ft1 table-wrap mode="anchored" t5 REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies HRP-coupled Protein-L antibody GenScript Cat# M00098 Fab 30 This study N/A HRP-coupled M2 anti-FLAG antibody Sigma-Aldrich Cat# A8592; RRID: AB_439702 Bacterial and Virus Strains E. coli cells BL21(DE3)pLysS Novogen Cat# 71403 Chemicals, Peptides, and Recombinant Proteins Protein-L beads GE Healthcare Cat# 17547802 C7pp peptide NovoPep N/A LB media LPS solution Cat# LB-005 Chloramphenicol Bio Basic Inc. Cat# 56757 Kanamycin LPS solution Cat# KAN025 M9 minimal salt media Sigma-Aldrich Cat# MKCF5138 IPTG LPS solution Cat# IPTG025 PMSF Bio Basic Inc. Cat# PB0425 ParatoneⓇ N oil Sigma-Aldrich Cat# HR2-643 n -dodecyl-β-D-maltopyranoside Anatrace Cat# D310S Deposited Data Rat βarr2-C7pp complex structure This study 6K3F Bos Taurus βarr2 Zhan et al., 2011 3P2D Bos Taurus βarr2 Chen et al., 2017 5TV1 Bovine βarr1 Milano et al., 2002 1JSY Bos Taurus βarr1 Kang et al., 2009 3GC3 Rat βarr1 Shukla et al., 2013 4JQI Bos Taurus βarr1 Han et al., 2001 1G4M Ambystoma tigrinum visual arr1 Sutton et al., 2005 1SUJ Bos Taurus visual arr1 Hirsch et al., 1999 1CF1 Bos Taurus visual arr1 Granzin et al., 2012 3UGX Bos Taurus visual arr1 Granzin et al., 2012 3UGU Bos Taurus visual arr1 Granzin et al., 2015 4ZRG Bos Taurus visual arr1 Granzin et al., 1998 1AYR Mouse visual arr1 Kang et al., 2015 4ZWJ Mouse visual arr1 Zhou et al., 2017 5W0P Squid visual arr1 Bandyopadhyay et al., 2018 6BK9 Experimental Models: Cell Lines HEK-293 cells ATCC Cat# CRL-3216 HTLA cells Barnea et al., 2008 N/A Recombinant DNA pET28a-βarr2 1-410 This study N/A pET28a-βarr2 1-356 This study N/A Software and Algorithms GraphPad Prism 6.0 GraphPad graphpad.com PyMol 1.8 Schrodinger LLC pymol.org Phaser McCoy et al., 2007 phenix-online.org COOT Emsley and Cowtan, 2004 mrc-lmb.cam.ac.uk REFMAC5 Murshudov et al., 1997 ccp4.ac.uk/html/refmac5.html XDS Kabsch, 2010 xds.mpimf-heidelberg.mpg.de ProteinLynx Global Server (PLGS) 2.4 Waters waters.com DynamX 2.0 Waters waters.com Other Ni-sepharose affinity column GE Healthcare Cat# 17256801 Desalting column GE Healthcare Cat# 17085101 HiTrap Q sepharose column GE Healthcare Cat# 17115401 HiLoad 16/60 Superdex 200 GE Healthcare Cat# 28989335 HiTrap heparin column GE Healthcare Cat# 17040701 96-well MaxiSorp polystyrene plates Sigma-Aldrich Cat# P6366 Open in a separate window Key Resources Table Resource Availability Lead Contact Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Hyung Ho Lee ( rk.ca.uns@eelohgnuyh ).

Techniques: Binding Assay

Key Resources Table

Journal: Structure (London, England : 1993)

Article Title: Crystal Structure of β-Arrestin 2 in Complex with CXCR7 Phosphopeptide

doi: 10.1016/j.str.2020.06.002

Figure Lengend Snippet: Key Resources Table

Article Snippet: table ft1 table-wrap mode="anchored" t5 REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies HRP-coupled Protein-L antibody GenScript Cat# M00098 Fab 30 This study N/A HRP-coupled M2 anti-FLAG antibody Sigma-Aldrich Cat# A8592; RRID: AB_439702 Bacterial and Virus Strains E. coli cells BL21(DE3)pLysS Novogen Cat# 71403 Chemicals, Peptides, and Recombinant Proteins Protein-L beads GE Healthcare Cat# 17547802 C7pp peptide NovoPep N/A LB media LPS solution Cat# LB-005 Chloramphenicol Bio Basic Inc. Cat# 56757 Kanamycin LPS solution Cat# KAN025 M9 minimal salt media Sigma-Aldrich Cat# MKCF5138 IPTG LPS solution Cat# IPTG025 PMSF Bio Basic Inc. Cat# PB0425 ParatoneⓇ N oil Sigma-Aldrich Cat# HR2-643 n -dodecyl-β-D-maltopyranoside Anatrace Cat# D310S Deposited Data Rat βarr2-C7pp complex structure This study 6K3F Bos Taurus βarr2 Zhan et al., 2011 3P2D Bos Taurus βarr2 Chen et al., 2017 5TV1 Bovine βarr1 Milano et al., 2002 1JSY Bos Taurus βarr1 Kang et al., 2009 3GC3 Rat βarr1 Shukla et al., 2013 4JQI Bos Taurus βarr1 Han et al., 2001 1G4M Ambystoma tigrinum visual arr1 Sutton et al., 2005 1SUJ Bos Taurus visual arr1 Hirsch et al., 1999 1CF1 Bos Taurus visual arr1 Granzin et al., 2012 3UGX Bos Taurus visual arr1 Granzin et al., 2012 3UGU Bos Taurus visual arr1 Granzin et al., 2015 4ZRG Bos Taurus visual arr1 Granzin et al., 1998 1AYR Mouse visual arr1 Kang et al., 2015 4ZWJ Mouse visual arr1 Zhou et al., 2017 5W0P Squid visual arr1 Bandyopadhyay et al., 2018 6BK9 Experimental Models: Cell Lines HEK-293 cells ATCC Cat# CRL-3216 HTLA cells Barnea et al., 2008 N/A Recombinant DNA pET28a-βarr2 1-410 This study N/A pET28a-βarr2 1-356 This study N/A Software and Algorithms GraphPad Prism 6.0 GraphPad graphpad.com PyMol 1.8 Schrodinger LLC pymol.org Phaser McCoy et al., 2007 phenix-online.org COOT Emsley and Cowtan, 2004 mrc-lmb.cam.ac.uk REFMAC5 Murshudov et al., 1997 ccp4.ac.uk/html/refmac5.html XDS Kabsch, 2010 xds.mpimf-heidelberg.mpg.de ProteinLynx Global Server (PLGS) 2.4 Waters waters.com DynamX 2.0 Waters waters.com Other Ni-sepharose affinity column GE Healthcare Cat# 17256801 Desalting column GE Healthcare Cat# 17085101 HiTrap Q sepharose column GE Healthcare Cat# 17115401 HiLoad 16/60 Superdex 200 GE Healthcare Cat# 28989335 HiTrap heparin column GE Healthcare Cat# 17040701 96-well MaxiSorp polystyrene plates Sigma-Aldrich Cat# P6366 Open in a separate window Key Resources Table Resource Availability Lead Contact Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Hyung Ho Lee ( rk.ca.uns@eelohgnuyh ).

Techniques: Recombinant, Software, Affinity Column

( A ) CCK8 assay was conducted to analyze the toxicity of different doses of BBR (1 μM, 2 μM, 4 μM, 8 μM, or 16 μM) in HMC3 cells. ( B-F ) HMC3 cells were divided into six groups: control, BBR (8 μM), LPS, LPS+BBR (2 μM), LPS+BBR (4 μM), and LPS+BBR (8 μM). For BBR and LPS co-treated group, HMC3 cells were treated with BBR for 3 h, followed by LPS exposure for 24 h. ( B and C ) IF assay was carried out to evaluate the levels of two indicators of inflammation, including iNOS and COX2. ( D-F ) ELISA was implemented to analyze the release of three pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) in the culture supernatant. ns: no statistically significant difference, * P< 0.05, ** P< 0.01, *** P< 0.001.

Journal: Physiological Research

Article Title: Berberine Exerts Neuroprotective Effects in Alzheimer’s Disease by Switching Microglia M1/M2 Polarization Through PI3K-AKT Signaling

doi: 10.33549/physiolres.935410

Figure Lengend Snippet: ( A ) CCK8 assay was conducted to analyze the toxicity of different doses of BBR (1 μM, 2 μM, 4 μM, 8 μM, or 16 μM) in HMC3 cells. ( B-F ) HMC3 cells were divided into six groups: control, BBR (8 μM), LPS, LPS+BBR (2 μM), LPS+BBR (4 μM), and LPS+BBR (8 μM). For BBR and LPS co-treated group, HMC3 cells were treated with BBR for 3 h, followed by LPS exposure for 24 h. ( B and C ) IF assay was carried out to evaluate the levels of two indicators of inflammation, including iNOS and COX2. ( D-F ) ELISA was implemented to analyze the release of three pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) in the culture supernatant. ns: no statistically significant difference, * P< 0.05, ** P< 0.01, *** P< 0.001.

Article Snippet: LPS (Cat. No. L8880) and BBR (Cat. No. SB8130) were purchased from Solarbio life sciences (Beijing, China).

Techniques: CCK-8 Assay, Control, Enzyme-linked Immunosorbent Assay

( A-D ) Aβ 1-42 -exposed SH-SY5Y cells were cultured in the conditioned medium from control, BBR-stimulated, LPS-stimulated, or BBR and LPS co-treated HMC3 cells. ( A ) CCK8 assay was employed to analyze the viability of SH-SY5Y cells. ( B and C ) The MMP and ROS in SH-SY5Y cells were determined through IF staining method of JC-1 and DCFH-DA, respectively. ( D ) Western blot assay was conducted to measure the protein levels of two apoptosis-associated markers (cleaved CASP3 and Bax) in SH-SY5Y cells. ns: no statistically significant difference, * P< 0.05, *** P< 0.001.

Journal: Physiological Research

Article Title: Berberine Exerts Neuroprotective Effects in Alzheimer’s Disease by Switching Microglia M1/M2 Polarization Through PI3K-AKT Signaling

doi: 10.33549/physiolres.935410

Figure Lengend Snippet: ( A-D ) Aβ 1-42 -exposed SH-SY5Y cells were cultured in the conditioned medium from control, BBR-stimulated, LPS-stimulated, or BBR and LPS co-treated HMC3 cells. ( A ) CCK8 assay was employed to analyze the viability of SH-SY5Y cells. ( B and C ) The MMP and ROS in SH-SY5Y cells were determined through IF staining method of JC-1 and DCFH-DA, respectively. ( D ) Western blot assay was conducted to measure the protein levels of two apoptosis-associated markers (cleaved CASP3 and Bax) in SH-SY5Y cells. ns: no statistically significant difference, * P< 0.05, *** P< 0.001.

Article Snippet: LPS (Cat. No. L8880) and BBR (Cat. No. SB8130) were purchased from Solarbio life sciences (Beijing, China).

Techniques: Cell Culture, Control, CCK-8 Assay, Staining, Western Blot

( A-C ) HMC3 cells were divided into five groups: control, BBR (8 μM), LPS, LPS+BBR (8 μM), LPS+BBR (8 μM) + LY294002. For BBR and LPS co-treated group, HMC3 cells were treated with BBR for 3 h, followed by LPS exposure for 24 h. For LPS, BBR, and LY294002 co-treated group, HMC3 cells were treated with BBR for 3 h, followed by LPS and LY294002 stimulation for 24 h. ( A ) The levels of p-PI3K, PI3K, p-AKT, and AKT in HMC3 cells were determined by western blot assay. ( B and C ) ELISA was employed to detect the release of two pro-inflammatory cytokines (IL-1β and IL-6) in the culture supernatant of HMC3 cells. ns: no statistically significant difference, ** P< 0.01, *** P< 0.001.

Journal: Physiological Research

Article Title: Berberine Exerts Neuroprotective Effects in Alzheimer’s Disease by Switching Microglia M1/M2 Polarization Through PI3K-AKT Signaling

doi: 10.33549/physiolres.935410

Figure Lengend Snippet: ( A-C ) HMC3 cells were divided into five groups: control, BBR (8 μM), LPS, LPS+BBR (8 μM), LPS+BBR (8 μM) + LY294002. For BBR and LPS co-treated group, HMC3 cells were treated with BBR for 3 h, followed by LPS exposure for 24 h. For LPS, BBR, and LY294002 co-treated group, HMC3 cells were treated with BBR for 3 h, followed by LPS and LY294002 stimulation for 24 h. ( A ) The levels of p-PI3K, PI3K, p-AKT, and AKT in HMC3 cells were determined by western blot assay. ( B and C ) ELISA was employed to detect the release of two pro-inflammatory cytokines (IL-1β and IL-6) in the culture supernatant of HMC3 cells. ns: no statistically significant difference, ** P< 0.01, *** P< 0.001.

Article Snippet: LPS (Cat. No. L8880) and BBR (Cat. No. SB8130) were purchased from Solarbio life sciences (Beijing, China).

Techniques: Control, Western Blot, Enzyme-linked Immunosorbent Assay

Elevated levels of BPI present in plasma and BAL of people with CF. (A , B) LPS levels in CF plasma and BAL correlated with CF-ABLE score. Quantification of an association between variables was achieved by Spearman correlation. (C , D) Comparative analysis of BPI present in plasma or BAL of Phe508del homozygous PWCF (CF), healthy controls (HC) or NCFB patients was performed by ELISA. (C) BPI levels were significantly increased in plasma of CF compared to HC (n=22 and n=14 subjects per group, respectively, p=0.007, Mann Whitney U-test). (D) BAL levels of BPI were significantly increased in CF (n=5) compared to HC (n=4) or NCFB patients (n=5) (p<0.0001, One-way ANOVA, followed by Bonferroni post-hoc test for selected groups). (E) BAL samples from HC, CF, NCFB or COPD were subjected to SDS-PAGE and Western blot analysis for BPI. An immuno-band of increased intensity for BPI was detected in CF BAL samples (top panels). Lower panel, a control immunoblot to ensure BPI specificity. The blot was halved, with one half probed with secondary antibody only with no BPI immune-bands visible (↑ indicates where blot was cut). Human BPI (hBPI) was used as a positive control. All measurements are means ± SEM from biological replicates.

Journal: Frontiers in Pharmacology

Article Title: Targeting IgG Autoantibodies for Improved Cytotoxicity of Bactericidal Permeability Increasing Protein in Cystic Fibrosis

doi: 10.3389/fphar.2020.01098

Figure Lengend Snippet: Elevated levels of BPI present in plasma and BAL of people with CF. (A , B) LPS levels in CF plasma and BAL correlated with CF-ABLE score. Quantification of an association between variables was achieved by Spearman correlation. (C , D) Comparative analysis of BPI present in plasma or BAL of Phe508del homozygous PWCF (CF), healthy controls (HC) or NCFB patients was performed by ELISA. (C) BPI levels were significantly increased in plasma of CF compared to HC (n=22 and n=14 subjects per group, respectively, p=0.007, Mann Whitney U-test). (D) BAL levels of BPI were significantly increased in CF (n=5) compared to HC (n=4) or NCFB patients (n=5) (p<0.0001, One-way ANOVA, followed by Bonferroni post-hoc test for selected groups). (E) BAL samples from HC, CF, NCFB or COPD were subjected to SDS-PAGE and Western blot analysis for BPI. An immuno-band of increased intensity for BPI was detected in CF BAL samples (top panels). Lower panel, a control immunoblot to ensure BPI specificity. The blot was halved, with one half probed with secondary antibody only with no BPI immune-bands visible (↑ indicates where blot was cut). Human BPI (hBPI) was used as a positive control. All measurements are means ± SEM from biological replicates.

Article Snippet: Lipopolysaccharide (LPS) was quantified in plasma and BAL of PWCF ( ) using an LPS ELISA (Cusabio: catalog number CSB-E09945h).

Techniques: Clinical Proteomics, Enzyme-linked Immunosorbent Assay, MANN-WHITNEY, SDS Page, Western Blot, Control, Positive Control

Increased levels of plasma autoantibodies and IgG-bound BPI in CF airway samples. (A) IgG autoantibodies against BPI were quantified in plasma of PWCF (CF, n=30) or healthy controls (HC, n=37). A significant increase in the titre of BPI autoantibodies were detected in CF (p<0.0001, Mann-Whitney U test). Positivity was set as 10 U/ml as indicated by the hatched line. All CF samples were positive for BPI autoantibodies. Increased circulating IgG BPI antibody level in CF individuals determined by ELISA. (B) Plasma samples from HC (n=38), CF (n=28) and CF individuals receiving ivacaftor treatment (n=10). No difference in levels of circulating anti-BPI IgG autoantibodies between CF and CF individuals receiving ivacaftor treatment (p=0.39). (C) Representative Coomassie blue stained SDS gel of purified IgG from CF BAL. Protein G Sepharose was used to isolate IgG from BAL of Phe508del homozygous PWCF. Starting BAL sample (St), unbound material (Un) or purified bound IgG (Bd) with or without DTT reduction are presented. Purified IgG (150 kDa, closed arrow), and the heavy (50 kDa) and light chains (25 kDa) of IgG are indicated (open arrows) (1 representative images of n = 5 biological repeats). (D) Protein G Sepharose was used to isolate IgG-BPI complexes from CF BAL. Reactions were analyzed by immunoblotting for BPI positivity using a mouse monoclonal anti-BPI antibody. Starting BAL sample (St), unbound material (Un) or IgG-bound BPI (Bd) are presented. Human BPI (hBPI) was used as a positive control (55 kDa). A control immunoblot to ensure BPI specificity omitted primary antibody (right hand panel), with no immune-band apparent. 3 representative images of n=5 biological repeats.

Journal: Frontiers in Pharmacology

Article Title: Targeting IgG Autoantibodies for Improved Cytotoxicity of Bactericidal Permeability Increasing Protein in Cystic Fibrosis

doi: 10.3389/fphar.2020.01098

Figure Lengend Snippet: Increased levels of plasma autoantibodies and IgG-bound BPI in CF airway samples. (A) IgG autoantibodies against BPI were quantified in plasma of PWCF (CF, n=30) or healthy controls (HC, n=37). A significant increase in the titre of BPI autoantibodies were detected in CF (p<0.0001, Mann-Whitney U test). Positivity was set as 10 U/ml as indicated by the hatched line. All CF samples were positive for BPI autoantibodies. Increased circulating IgG BPI antibody level in CF individuals determined by ELISA. (B) Plasma samples from HC (n=38), CF (n=28) and CF individuals receiving ivacaftor treatment (n=10). No difference in levels of circulating anti-BPI IgG autoantibodies between CF and CF individuals receiving ivacaftor treatment (p=0.39). (C) Representative Coomassie blue stained SDS gel of purified IgG from CF BAL. Protein G Sepharose was used to isolate IgG from BAL of Phe508del homozygous PWCF. Starting BAL sample (St), unbound material (Un) or purified bound IgG (Bd) with or without DTT reduction are presented. Purified IgG (150 kDa, closed arrow), and the heavy (50 kDa) and light chains (25 kDa) of IgG are indicated (open arrows) (1 representative images of n = 5 biological repeats). (D) Protein G Sepharose was used to isolate IgG-BPI complexes from CF BAL. Reactions were analyzed by immunoblotting for BPI positivity using a mouse monoclonal anti-BPI antibody. Starting BAL sample (St), unbound material (Un) or IgG-bound BPI (Bd) are presented. Human BPI (hBPI) was used as a positive control (55 kDa). A control immunoblot to ensure BPI specificity omitted primary antibody (right hand panel), with no immune-band apparent. 3 representative images of n=5 biological repeats.

Article Snippet: Lipopolysaccharide (LPS) was quantified in plasma and BAL of PWCF ( ) using an LPS ELISA (Cusabio: catalog number CSB-E09945h).

Techniques: Clinical Proteomics, MANN-WHITNEY, Enzyme-linked Immunosorbent Assay, Staining, SDS-Gel, Purification, Western Blot, Positive Control, Control